[go: up one dir, main page]

WO2000020584A3 - Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 - Google Patents

Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 Download PDF

Info

Publication number
WO2000020584A3
WO2000020584A3 PCT/US1999/022576 US9922576W WO0020584A3 WO 2000020584 A3 WO2000020584 A3 WO 2000020584A3 US 9922576 W US9922576 W US 9922576W WO 0020584 A3 WO0020584 A3 WO 0020584A3
Authority
WO
WIPO (PCT)
Prior art keywords
pancreas
cancers
colon
prostate
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/022576
Other languages
French (fr)
Other versions
WO2000020584A9 (en
WO2000020584A2 (en
Inventor
Daniel E Afar
Rene S Hubert
Stephen Chappell Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Priority to EP99954686A priority Critical patent/EP1117794A2/en
Priority to AU10975/00A priority patent/AU1097500A/en
Priority to CA002344552A priority patent/CA2344552A1/en
Priority to IL14231099A priority patent/IL142310A0/en
Publication of WO2000020584A2 publication Critical patent/WO2000020584A2/en
Publication of WO2000020584A3 publication Critical patent/WO2000020584A3/en
Publication of WO2000020584A9 publication Critical patent/WO2000020584A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A novel human gene expressed in cancers of the prostate, bladder, pancreas, colon, cervix and ovary is described. A full length cDNA encoding a putative transcription factor exhibiting a high degree of homology to murine EHF and human ESX is provided.
PCT/US1999/022576 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 Ceased WO2000020584A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP99954686A EP1117794A2 (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
AU10975/00A AU1097500A (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
CA002344552A CA2344552A1 (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
IL14231099A IL142310A0 (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10274498P 1998-10-02 1998-10-02
US60/102,744 1998-10-02
US14644799P 1999-07-29 1999-07-29
US60/146,447 1999-07-29

Publications (3)

Publication Number Publication Date
WO2000020584A2 WO2000020584A2 (en) 2000-04-13
WO2000020584A3 true WO2000020584A3 (en) 2000-07-06
WO2000020584A9 WO2000020584A9 (en) 2000-08-31

Family

ID=26799687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/022576 Ceased WO2000020584A2 (en) 1998-10-02 1999-10-02 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6

Country Status (5)

Country Link
EP (1) EP1117794A2 (en)
AU (1) AU1097500A (en)
CA (1) CA2344552A1 (en)
IL (1) IL142310A0 (en)
WO (1) WO2000020584A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037093A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
WO1998037418A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and methods for their use
WO1999037809A1 (en) * 1998-01-21 1999-07-29 Axys Pharmaceuticals, Inc. Asthma related genes
WO1999062942A2 (en) * 1998-06-01 1999-12-09 Urogenesys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
WO2000004149A2 (en) * 1998-07-14 2000-01-27 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037093A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
WO1998037418A2 (en) * 1997-02-25 1998-08-27 Corixa Corporation Compounds for immunodiagnosis of prostate cancer and methods for their use
WO1999037809A1 (en) * 1998-01-21 1999-07-29 Axys Pharmaceuticals, Inc. Asthma related genes
WO1999062942A2 (en) * 1998-06-01 1999-12-09 Urogenesys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
WO2000004149A2 (en) * 1998-07-14 2000-01-27 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BOCHERT M A ET AL: "MOLECULAR CLONING AND EXPRESSION OF EHF, A NEW MEMBER OF THE ETS TRANSCRIPTION FACTOR/ONCOPROTEIN GENE FAMILY", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 246, no. 1, 1998, pages 176 - 181, XP000867344, ISSN: 0006-291X *
CHANG C -H ET AL: "ESX: A STRUCTURALLY UNIQUE ETS OVEREXPRESSED EARLY DURING HUMAN BREAST TUMORIGENESIS", ONCOGENE,GB,BASINGSTOKE, HANTS, vol. 14, no. 13, 1997, pages 1617 - 1622, XP000870110, ISSN: 0950-9232 *
L.A. KLEINBAUM ET AL.: "Human chromosomal localization, tissue/tumor expression, and regulatory function of the ets family gene EHF.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,US,ACADEMIC PRESS INC. ORLANDO, FL, vol. 264, 1999, pages 119 - 126, XP002136361 *

Also Published As

Publication number Publication date
WO2000020584A9 (en) 2000-08-31
IL142310A0 (en) 2002-03-10
CA2344552A1 (en) 2000-04-13
EP1117794A2 (en) 2001-07-25
AU1097500A (en) 2000-04-26
WO2000020584A2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
CA98438S (en) Spout
AU144991S (en) Bottle
CA97779S (en) Toilet
ATE380820T1 (en) MURINE ALPHA(1,3)-FUCOSYLTRANSFERASE (FUC-TVII)
CA97229S (en) Escutcheon
AU3361895A (en) Digital radio with vocoding encrypting codec
CA96618S (en) Beer cask with tap
ZA200108240B (en) Biomas gasification furnace and methanol synthesis system making use of gas produced through biomass gasification.
CA2256645A1 (en) Recombinant .alpha.-2,3-sialyltransferases and their uses
CA99703S (en) Airplane
WO2000020584A3 (en) Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
CA2245099A1 (en) Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
CA2421803A1 (en) Thin, soft bath tissue
CA95790S (en) Lavatory
DK0809695T3 (en) Transcription factor E2F-5
WO2000012709A3 (en) Phelix: a testis-specific protein expressed in cancer
CA97879S (en) Faucet
CA97032S (en) Multi-positional chair
WO1999029720A3 (en) Mammalian alpha helical protein-1
AU3848397A (en) Water outflow for a sanitary fitting
IT1284689B1 (en) LOCK, WITH SAFETY DEVICE TO ENABLE THE INTRODUCTION OF THE KEY IN THE LOCK.
AU7069498A (en) Human theta subunit of the gaba-a receptor
CA97176S (en) Faucet
CA97180S (en) Faucet
IT235640Y1 (en) BIDET WITH TAP ARRANGED FRONT OF THE USER.

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 10975

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: C2

Designated state(s): AT AT AU BR CA CH CN DE DE DK DK ES FI FI GB IL JP KR MX NO NZ RU SE SG

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/9-9/9, DRAWINGS, REPLACED BY NEW PAGES 1/10-10/10; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2344552

Country of ref document: CA

Ref country code: CA

Ref document number: 2344552

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 10975/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999954686

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999954686

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999954686

Country of ref document: EP